USER - LCID EDIT and BLUE among pre market gainers
Arena Pharmaceuticals (NASDAQ:ARNA) +90% on acquisition by Pfizer. Foghorn Therapeutics (NASDAQ:FHTX) +38% after collaborating with Lilly in oncology medicines. BELLUS Health (NASDAQ:BLU) +36% on positive BLU-5937 data in mid-stage chronic cough study. Petros Pharmaceuticals (NASDAQ:PTPI) +18%. Clear Channel Outdoor (NYSE:CCO) +12% on raising Q4 guidance, reviews strategic European Business alternatives. Harley-Davidson (NYSE:HOG) +12% announces SPAC deal for LiveWire. UserTesting (NYSE:USER) +11%. Turquoise Hill Resources (NYSE:TRQ) +11%. Stran & Company (NASDAQ:STRNW) +10%. bluebird bio (NASDAQ:BLUE) +9% new and updated data demonstrating sustained treatment response in patients treated in largest sickle cell gene therapy program to-date presented at ASH21 and published in NEJM. Aptevo Therapeutics (NASDAQ:APVO) +9%. Biofrontera (NASDAQ:BFRI) +10%. American Virtual Cloud Technologies (NASDAQ:AVCT) +9%. Arbutus Biopharma (NASDAQ:ABUS) +6% and Qilu Pharmaceutical enter into an exclusive licensing agreement and strategic partnership to develop and commercialize AB-729 in mainland China, Hong Kong, Macau and Taiwan. Midatech Pharma plc (NASDAQ:MTP) +7% announces IND application for MTX110 study in GBM effective. Aries I Acquisition (NASDAQ:RAMMU) +6%. Galecto
For further details see:
LCID, EDIT and BLUE among pre market gainers